Most Read News

Its net profit for FY 25 rose over threefold to ₹608.33 crore, against ₹181.05 crore in FY24

Its operating revenue in the quarter also stayed nearly flat at ₹2,055 crore as against ₹2,110 crore in Q4 FY24

On May 26, Sensex was up 455.37 points to end at 82,176.45. Meanwhile, the Nifty was up 148.00 points to close its day at 25,001.15.

Revenue from operations was at ₹767.5 crore, 12.7% higher than ₹681 crore reported in the March quarter of FY24

RBI noticed that Union Bank did not transfer the eligible unclaimed amounts to the DEAF within the prescribed time, violating the rules in force.

Revenue from operations was down by 20.3% y-o-y to ₹1,360.9 crore in Q4 FY25 from ₹1,708.2 crore in Q4 FY24

Gangwal and The Chinkerpoo Family Trust will offload the stake at a floor price of ₹5,175 per share.

Here are some of the stocks that may see significant price movement today: Lupin, IndiGo, Nazara Tech, Aurobindo Pharma, etc.

Annual income at the company also grew by a big margin of ₹31,724 crore in FY25 from ₹29,002 crore in FY24, up 9.4% on yearly basis

Domestic patient volumes rose over 15% year-on-year in the March quarter, helping to offset a sharp 53% decline in medical tourism from Bangladesh